These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31353131)

  • 1. Coadministration of Sublingual Immunotherapy Tablets and Management of Potential Adverse Effects: Austrian, German, and Swiss Expert Recommendations.
    Sturm GJ; Vogelberg C; Marchon M; Horn A; Vitzthum HG; Memar-Baschi MP; Kleine-Tebbe J
    Clin Ther; 2019 Sep; 41(9):1880-1888. PubMed ID: 31353131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.
    Maloney J; Berman G; Gagnon R; Bernstein DI; Nelson HS; Kleine-Tebbe J; Kaur A; Li Q; Nolte H
    J Allergy Clin Immunol Pract; 2016; 4(2):301-9.e2. PubMed ID: 26755098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.
    Bernstein DI; Bardelas JA; Svanholm Fogh B; Kaur A; Li Z; Nolte H
    Postgrad Med; 2017 Aug; 129(6):590-597. PubMed ID: 28326906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.
    Nolte H; Maloney J
    Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of Tablet Formulation on Allergen Release Kinetics and Efficiency: Comparison of Freeze-dried and Compressed Grass Pollen Sublingual Allergy Immunotherapy Tablet Formulations.
    Lund K; Kito H; Skydtsgaard MB; Nakazawa H; Ohashi-Doi K; Lawton S
    Clin Ther; 2019 Apr; 41(4):742-753. PubMed ID: 30885398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.
    Durham SR; Creticos PS; Nelson HS; Li Z; Kaur A; Meltzer EO; Nolte H
    J Allergy Clin Immunol; 2016 Oct; 138(4):1081-1088.e4. PubMed ID: 27527264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study.
    Reiber R; Keller M; Keller W; Wolf H; Schnitker J; Wüstenberg E
    Clin Transl Allergy; 2015; 6():9. PubMed ID: 26958338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of sublingual immunotherapy tablets and drops.
    Tankersley M; Han JK; Nolte H
    Ann Allergy Asthma Immunol; 2020 Jun; 124(6):573-582. PubMed ID: 31923544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual Immunotherapy for the Polyallergic Patient.
    Pepper AN; Calderón MA; Casale TB
    J Allergy Clin Immunol Pract; 2017; 5(1):41-45. PubMed ID: 27452888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tablet-based sublingual immunotherapy for respiratory allergy.
    Prieto L
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():30-35. PubMed ID: 29146015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of the SQ Tree SLIT Tablet in Adults.
    Birk AO; Andersen JS; Villesen HH; Steffensen MA; Calderon MA
    Clin Ther; 2017 Sep; 39(9):1858-1867. PubMed ID: 28844318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents.
    Eberle P; Brueck H; Gall R; Hadler M; Sieber J; Karagiannis E
    Pediatr Allergy Immunol; 2014 Dec; 25(8):760-6. PubMed ID: 25378225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus report.
    Li JT; Bernstein DI; Calderon MA; Casale TB; Cox L; Passalacqua G; Pfaar O; Papadopoulos NG
    J Allergy Clin Immunol; 2016 Feb; 137(2):369-76. PubMed ID: 26371843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum treatment strategies for polyallergic patients - analysis of a large observational trial.
    Shah-Hosseini K; Mioc K; Hadler M; Karagiannis E; Mösges R
    Curr Med Res Opin; 2015 Dec; 31(12):2249-59. PubMed ID: 26366617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?
    Cavaliere C; Incorvaia C; Begvarfaj E; Orlando MP; Turchetta R; Musacchio A; Ralli M; Ciofalo A; Greco A; de Vincentiis M; Masieri S
    Expert Opin Drug Saf; 2021 Mar; 20(3):259-264. PubMed ID: 33427529
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
    Maloney J; Durham S; Skoner D; Dahl R; Bufe A; Bernstein D; Murphy K; Waserman S; Berman G; White M; Kaur A; Nolte H
    Allergy; 2015 Mar; 70(3):302-9. PubMed ID: 25495666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
    Gotoh M; Okubo K; Yuta A; Ogawa Y; Nagakura H; Ueyama S; Ueyama T; Kawashima K; Yamamoto M; Fujieda S; Sakashita M; Sakamoto H; Iwasaki N; Mori E; Endo T; Ohta N; Kitazawa H; Okano M; Asako M; Takada M; Terada T; Inaka Y; Yonekura S; Matsuoka T; Kaneko S; Hata H; Hijikata N; Tanaka H; Masuyama K; Okamoto Y
    Allergol Int; 2020 Jan; 69(1):104-110. PubMed ID: 31421989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.
    Nelson HS
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1437-51. PubMed ID: 25340426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual Immunotherapy Dosing Regimens: What Is Ideal?
    Jin JJ; Li JT; Klimek L; Pfaar O
    J Allergy Clin Immunol Pract; 2017; 5(1):1-10. PubMed ID: 28065336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.